The invention discloses a method for predicting the
curative effect of
triple negative breast cancer immunotherapy by spatially quantizing CD39 + CD103 + CD8 + T cells, and relates to the technical field of
biology.The method comprises the following specific steps that S1, an FFPE
tumor tissue sample of a TNBC subject before
immunotherapy is obtained, and a continuous section with the thickness of 3-5 microns is prepared and attached to a positive charge
glass slide; s2,
staining the section by using a combination containing CD8 / CD103 / CD39 / Pan-CK antibodies through a TSA sequential
staining method, and then re-
staining cell nucleuses by using
DAPI; according to the method, spatial quantitative analysis is performed on a specific CD39 + CD103 + CD8 +
T cell subset, a percentage index of target cells in CD8 + T cells and an average distance index of the target cells and nearest Pan-CK positive cells in a
cancer nest region are set, and the target cells are determined according to comparison between the two indexes and a preset threshold value. According to the method, whether a subject is a potential benefit crowd treated by an anti-PD-1 / PD-L1
immune checkpoint inhibitor or not is accurately judged, a standardized technical means is provided for clinically screening the potential benefit crowd for
immunotherapy, the accuracy and effectiveness of triple-negative
breast cancer immunotherapy are effectively improved, and invalid treatment is reduced.